BIOMAT Database Logo BIOMAT Database Logo

Type V hyperlipoproteinaemia: a family study. 1975

J Raleigh, and J Reddy, and D Friedlander, and R Hope

Family screening for hyperlipoproteinaemia was undertaken when a patient presented with myocardial infarction in association with Type V hyperlipoproteinaemia. The clinical features of this unusual form of hyperlipoproteinaemia are discussed together with its frequency in the general population and in relatives of affected patients.

UI MeSH Term Description Entries
D006949 Hyperlipidemias Conditions with excess LIPIDS in the blood. Hyperlipemia,Hyperlipidemia,Lipemia,Lipidemia,Hyperlipemias,Lipemias,Lipidemias
D008079 Lipoproteins, VLDL A class of lipoproteins of very light (0.93-1.006 g/ml) large size (30-80 nm) particles with a core composed mainly of TRIGLYCERIDES and a surface monolayer of PHOSPHOLIPIDS and CHOLESTEROL into which are imbedded the apolipoproteins B, E, and C. VLDL facilitates the transport of endogenously made triglycerides to extrahepatic tissues. As triglycerides and Apo C are removed, VLDL is converted to INTERMEDIATE-DENSITY LIPOPROTEINS, then to LOW-DENSITY LIPOPROTEINS from which cholesterol is delivered to the extrahepatic tissues. Pre-beta-Lipoprotein,Prebeta-Lipoprotein,Prebeta-Lipoproteins,Very Low Density Lipoprotein,Very-Low-Density Lipoprotein,Very-Low-Density Lipoproteins,Lipoprotein VLDL II,Lipoproteins, VLDL I,Lipoproteins, VLDL III,Lipoproteins, VLDL1,Lipoproteins, VLDL2,Lipoproteins, VLDL3,Pre-beta-Lipoproteins,Lipoprotein, Very-Low-Density,Lipoproteins, Very-Low-Density,Pre beta Lipoprotein,Pre beta Lipoproteins,Prebeta Lipoprotein,Prebeta Lipoproteins,VLDL Lipoproteins,VLDL1 Lipoproteins,VLDL2 Lipoproteins,VLDL3 Lipoproteins,Very Low Density Lipoproteins
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002914 Chylomicrons A class of lipoproteins that carry dietary CHOLESTEROL and TRIGLYCERIDES from the SMALL INTESTINE to the tissues. Their density (0.93-1.006 g/ml) is the same as that of VERY-LOW-DENSITY LIPOPROTEINS. Chylomicron
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

J Raleigh, and J Reddy, and D Friedlander, and R Hope
Type V hyperlipoproteinaemia.
March 1973, Clinics in endocrinology and metabolism,
J Raleigh, and J Reddy, and D Friedlander, and R Hope
Type V hyperlipoproteinaemia in neonates.
September 1987, Archives of disease in childhood,
J Raleigh, and J Reddy, and D Friedlander, and R Hope
Primary type I hyperlipoproteinaemia--a metabolic and family study.
December 1979, Australian and New Zealand journal of medicine,
J Raleigh, and J Reddy, and D Friedlander, and R Hope
Familial type II hyperlipoproteinaemia in a Chinese family.
May 1973, The Medical journal of Australia,
J Raleigh, and J Reddy, and D Friedlander, and R Hope
Apolipoprotein E mutations, type V hyperlipoproteinaemia and diet.
June 2000, The British journal of nutrition,
J Raleigh, and J Reddy, and D Friedlander, and R Hope
Type V hyperlipoproteinaemia re-visted: findings in a sydney population.
June 1975, Australian and New Zealand journal of medicine,
J Raleigh, and J Reddy, and D Friedlander, and R Hope
A clinical syndrome characteristic of primary Type IV-V hyperlipoproteinaemia.
March 1974, The British journal of dermatology,
J Raleigh, and J Reddy, and D Friedlander, and R Hope
[Xantinol-nicotinate in primary type-V hyperlipoproteinaemia (author's transl)].
September 1976, Deutsche medizinische Wochenschrift (1946),
J Raleigh, and J Reddy, and D Friedlander, and R Hope
Genetic study of hyperlipoproteinaemia types IV and V.
October 1977, Clinical genetics,
J Raleigh, and J Reddy, and D Friedlander, and R Hope
[Eye changes in hyperlipoproteinaemia type IV and V (author's transl)].
April 1977, Klinika oczna,
Copied contents to your clipboard!